Docket #: S13-149
Neurexin-1alpha knockout mouse model of autism and schizophrenia
Mouse model used to replicate a gene mutation that has been repeatedly observed in autism and schizophrenia patients.
This invention is jointly owned with UT Southerwestern. For licensing information please contact: TechnologyDevelopment@utsouthwestern.edu
Applications
- Can potentially be used for screening for drugs against neuropsychiatric disorders, for validating drug candidates, or for exploring pathogenetic mechanisms involved in neuropsychiatric disorders
Advantages
- Animal models of schizophrenia and autism are notoriously difficult to generate, and this model replicates not only the genetic nature of these conditions, but also mimics some of the symptoms observed in the conditions.
Publications
- PNAS, October 20, 2009, Vol. 106, No. 42 17908-18003
Similar Technologies
-
Selective modulation of anxiety features S13-095Selective modulation of anxiety features
-
A method for rapid multi-contrast brain imaging S14-295A method for rapid multi-contrast brain imaging
-
Conductive Graphene/Carbon Nanofiber Composite Scaffold for Neural Tissue Engineering S17-314Conductive Graphene/Carbon Nanofiber Composite Scaffold for Neural Tissue Engineering